In most tumors, treatment of GBM-TICs with BMP7 inhibits proliferation and promotes differentiation [4]; however, in a minority of GBMs, BMPs fail to induce differentiation of GBM-TICs due to epigenetic silencing of BMPR1B [8]. Here, BMPR1B is linked to glioblastoma.